Blood cancer treatment continues to evolve with the development of medicines designed to address specific types of cancer. Acalataz 100, from Zuvius Lifesciences, is an oral oncology medicine containing Acalabrutinib 100 mg. It is part of the OncoAce portfolio of oncology products.
What Is Acalataz 100?
Acalataz 100 contains Acalabrutinib 100 mg and is available in capsule form for oral use. Acalabrutinib is a targeted medicine used in the treatment of certain blood cancers.
As a prescription medicine, Acalataz 100 should be used only under the guidance of a qualified healthcare professional.
What Is Acalabrutinib Used For?
Acalabrutinib is used to treat certain types of blood cancer, including:
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma (SLL)
- Mantle Cell Lymphoma (MCL) in certain patients
These conditions affect certain white blood cells and can require specialised treatment depending on the individual's diagnosis and medical history.
The choice of treatment is different for every patient. A healthcare professional determines whether Acalataz 100 is appropriate based on the type of cancer and the patient's overall condition.
Acalataz 100: Key Product Information
| Brand | Acalataz 100 |
|---|---|
| Active Ingredient | Acalabrutinib |
| Strength | 100 mg |
| Dosage Form | Capsules |
| Route of Administration | Oral |
| Pack Size | 30 Capsules |
Acalataz 100 is part of Zuvius Lifesciences' OncoAce range, which focuses on medicines for different areas of cancer care.
Why Acalabrutinib Is Important in Blood Cancer Care
Modern cancer treatment increasingly includes medicines that are designed to act on specific processes involved in cancer cells. Acalabrutinib is one such targeted medicine and has an established role in the treatment of certain blood cancers.
Its use, however, is specific to particular conditions and patients. It should not be considered a general treatment for all types of cancer or blood cancer.
Important Information
Acalataz 100 is a prescription medicine and should be taken only as directed by a qualified healthcare professional. The recommended treatment and duration may vary depending on the patient's condition.
Patients should discuss their medical history and other medicines they are taking with their doctor before starting treatment. They should also seek medical advice if they experience any unusual or concerning symptoms during treatment.
Acalataz 100 should be used strictly under medical supervision.
Frequently Asked Questions
What is Acalataz 100?
Acalataz 100 is an oral capsule containing Acalabrutinib 100 mg, developed by Zuvius Lifesciences as part of its OncoAce oncology portfolio.
What is Acalabrutinib used for?
Acalabrutinib is used for the treatment of certain blood cancers, including CLL, SLL and certain cases of mantle cell lymphoma.
Is Acalataz 100 a prescription medicine?
Yes. Acalataz 100 should be used only under the guidance and supervision of a qualified healthcare professional.
Can Acalataz 100 be used for every type of blood cancer?
No. Acalataz 100 is intended for specific blood cancer conditions. A doctor should determine whether it is suitable for an individual patient.
Acalataz 100 by Zuvius Lifesciences
With Acalataz 100, Zuvius Lifesciences adds an Acalabrutinib-based medicine to its growing OncoAce oncology portfolio. The product reflects the company's focus on expanding its range of medicines across different areas of cancer care.
Acalataz 100 — Acalabrutinib Capsules 100 mg
For oral use only.
For oncology medicines, always check the approved product information and consult a qualified cancer specialist before use.